Buscar resultados de ensayos clínicos
Angiomatosis - 46 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease Condición:
Fecha: 2009-11-16 Intervenciones: Drug: Avastin Patients will receive Bevacizumab (Avastin) 10mg/kg IV every two weeks for 6 months |
Completed |
Nombre del estudio: Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 Condición:
|
Active, not recruiting |
Nombre del estudio: Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease Condición:
Fecha: 2000-06-06 |
Active, not recruiting |
Nombre del estudio: Von Hippel-Lindau Disease Genetic Epidemiology Study Condición:
Fecha: 1999-11-03 |
Completed |
Nombre del estudio: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy Condición:
|
Active, not recruiting |
Nombre del estudio: Pazopanib in Von Hippel-Lindau (VHL) Syndrome Condición: Von Hippel-Lindau Syndrome Fecha: 2011-09-15 Intervenciones: Drug: Pazopanib 800 mg by mouth once daily for up to six, four week cycles. |
Terminated |
Nombre del estudio: TKI 258 in Von Hippel-Lindau Syndrome (VHL) Condición: Von Hippel-Lindau Syndrome Fecha: 2010-12-22 Intervenciones: Drug: Dovitinib 500 mg (5 capsules) daily by mouth on Days 1-5, 8-12, 15-19, and 22-26 of each 28-day cy |
Terminated |
Nombre del estudio: Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome Condición: Von Hippel-Lindau Syndrome Fecha: 2008-05-06 Intervenciones: Drug: Sunitinib Malate Participants were expected to receive 9 months of sunitinib malate therapy admini |
Completed |
Nombre del estudio: Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome Condición: Von Hippel-Lindau Syndrome Fecha: 2004-08-12 Intervenciones: Drug: Ranibizumab |
Recruiting |
Nombre del estudio: PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma Condición:
|